World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
46
Citations
24109
World Ranking
4561
National Ranking
2055

Arlene Hurley publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arlene Hurley sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 62 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arlene Hurley D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arlene Hurley sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 46 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Arlene Hurley is affiliated with Rockefeller University in the United States and specializes primarily in Medicine and Biochemistry, Genetics and Molecular Biology. Their research focuses on infectious diseases, molecular biology, immunology, cancer research, and neurology, with a particular emphasis on SARS-CoV-2 and COVID-19 research.

Their recent publications include the following papers:

  • Convergent antibody responses to SARS-CoV-2 in convalescent individuals (2020, Nature)
  • Evolution of antibody immunity to SARS-CoV-2 (2021, Nature)
  • mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants (2021, Nature)
  • Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies (2020, Cell)
  • Evolution of Antibody Immunity to SARS-CoV-2 (2020, bioRxiv - Cold Spring Harbor Laboratory)

Frequent co-authors working alongside Hurley include Marina Caskey, Michel C. Nussenzweig, Christian Gaebler, Thiago Y. Oliveira, and Davide F. Robbiani.

The scientist has published extensively in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature
  • Cell
  • The Journal of Experimental Medicine
  • Cell Host & Microbe

The main topics covered throughout Hurley's body of research include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • Long-Term Effects of COVID-19
  • Immunotherapy and Immune Responses
  • Animal Virus Infections Studies
  • Monoclonal and Polyclonal Antibodies Research

Hurley's scientific contributions offer data relevant to understanding antibody responses to viral infections, especially in the context of the ongoing COVID-19 pandemic, and they engage with molecular and immunological approaches. Their collaborations reflect a network of researchers dedicated to various aspects of immune system dynamics and virus-host interactions.

Best Publications

  • Convergent antibody responses to SARS-CoV-2 in convalescent individuals.

    Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi

  • Decay characteristics of HIV-1-infected compartments during combination therapy

    Alan S. Perelson;Paulina Essunger;Yunzhen Cao;Mika Vesanen

  • Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.

    G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar

  • Evolution of antibody immunity to SARS-CoV-2.

    Christian Gaebler;Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch

  • Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

    Saurabh Mehandru;Michael A. Poles;Michael A. Poles;Klara Tenner-Racz;Amir Horowitz;Amir Horowitz

  • mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.

    Zijun Wang;Fabian Schmidt;Yiska Weisblum;Frauke Muecksch

  • Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.

    Johannes F. Scheid;Hugo Mouquet;Beatrix Ueberheide;Ron Diskin

  • Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals

    Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman

  • Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.

    Linqi Zhang;B. Ramratnam;K. Tenner-Racz;Yuxian He

  • Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.

    Christopher O. Barnes;Anthony P. West;Kathryn E. Huey-Tubman;Magnus A.G. Hoffmann

  • HIV-1 drug resistance in newly infected individuals.

    Daniel Boden;Arlene Hurley;Linqi Zhang;Yunzhen Cao

  • A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-1 Infection

    Markowitz M;Saag M;Powderly Wg;Hurley Am

  • Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

    Bharat Ramratnam;Sebastian Bonhoeffer;James Binley;Arlene Hurley

  • The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.

    Bharat Ramratnam;John E. Mittler;Linqi Zhang;Daniel Boden

  • A Novel Antiviral Intervention Results in More Accurate Assessment of Human Immunodeficiency Virus Type 1 Replication Dynamics and T-Cell Decay In Vivo

    Martin Markowitz;Michael Louie;Arlene Hurley;Eugene Sun

  • Decay Kinetics of Human Immunodeficiency Virus-Specific Effector Cytotoxic T Lymphocytes after Combination Antiretroviral Therapy

    G S Ogg;X Jin;S Bonhoeffer;P Moss

  • Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

    Davide F. Robbiani;Leonia Bozzacco;Jennifer R. Keeffe;Ricardo Khouri

  • HIV-1 Antigen–specific and –nonspecific B Cell Responses Are Sensitive to Combination Antiretroviral Therapy

    Lynn Morris;James M. Binley;Brian A. Clas;Sebastian Bonhoeffer

  • Use of Real-Time PCR and Molecular Beacons To Detect Virus Replication in Human Immunodeficiency Virus Type 1-Infected Individuals on Prolonged Effective Antiretroviral Therapy

    S. R. Lewin;M. Vesanen;L. Kostrikis;A. Hurley

  • HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

    Gabriel M. Ortiz;Douglas F. Nixon;Alexandra Trkola;James Binley

  • Evolution of Antibody Immunity to SARS-CoV-2

    Christian Gaebler;Zijun Wang;Julio C C Lorenzi;Frauke Muecksch

Frequent Co-Authors

David D. Ho
David D. Ho Columbia University
Michel C. Nussenzweig
Michel C. Nussenzweig Rockefeller University
Martin Markowitz
Martin Markowitz Rockefeller University
Marina Caskey
Marina Caskey Rockefeller University
Paul D. Bieniasz
Paul D. Bieniasz Rockefeller University
Thiago Y. Oliveira
Thiago Y. Oliveira Rockefeller University
Pamela J. Bjorkman
Pamela J. Bjorkman California Institute of Technology
Davide F. Robbiani
Davide F. Robbiani Universita della Svizzera Italiana
Alan S. Perelson
Alan S. Perelson Los Alamos National Laboratory
Anna Gazumyan
Anna Gazumyan Rockefeller University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology opens the door to various allied health careers that combine science with patient care. Many students explore related online degrees to complement their expertise, especially in nursing and healthcare management. For those interested in fast entry into the healthcare field, options like the easiest absn to get into offer accelerated paths to becoming a registered nurse.

Practical nursing roles can also be a strategic step forward, with several schools offering easy lpn programs to get into. These programs provide foundational clinical experience important for immunology-related healthcare settings.

For those seeking advanced practice roles, easy nurse practitioner programs to get into enable students to specialize further while balancing flexibility and quality education. One promising specialization is psychiatric mental health, where programs with best pmhnp programs with best clinical placement rates help ensure robust practical training alongside theoretical knowledge.

These related pathways not only enhance career opportunities but also strengthen the critical understanding of immune responses in varied clinical environments.

Best Scientists Citing Arlene Hurley

Trending Scientists

Recently Published Articles